Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP is a generic product labeled by Actavis Pharma, Inc., priced at $5.3136 per EA under NDC 00591264101. Its NADAC has been published 470 times since Feb 19, 2014.
FDA first approved this application on Jun 10, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP
Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateStrength
300; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591264101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA076560FDA Approved
6/10/2004
TE Code
AB
On Market Since
7/29/2013
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has been published 470 times since Feb 19, 2014, and over the history we have for it it has risen 34.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3136 per EA |
|---|---|
| All-time high | $5.8722 (Dec 11, 2019) |
| All-time low | $3.9515 (Feb 19, 2014) |
| 52-week high | $5.3507 |
| 52-week low | $4.9748 |
| Median price | $5.1124 |
| Average price | $5.1232 |
| Largest weekly change | +14.8% (Jun 17, 2015) |
| Weeks tracked | 470 |
| Tracking since | Feb 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP, manufactured by Actavis Pharma, Inc., is $5.3136 per EA (NDC 00591264101), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has risen 34.5%. It has been tracked across 470 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
Since Feb 19, 2014, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has ranged from a low of $3.9515 (Feb 19, 2014) to a high of $5.8722 (Dec 11, 2019), with a median of $5.1124 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP (NDC 00591264101) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.